Moons LMG - Search Results

1

Risk for Incomplete Resection after Macroscopic Radical Endoscopic Resection of T1 Colorectal Cancer: A Multicenter Cohort Study.

Backes Y, de Vos Tot Nederveen Cappel WH, van Bergeijk J, Ter Borg F, Schwartz MP, Spanier BWM, Geesing JMJ, Kessels K, Kerkhof M, Groen JN, Wolfhagen FHJ, Seerden TCJ, van Lelyveld N, Offerhaus GJA, Siersema PD, Lacle MM, Moons LMG. Backes Y, et al. Among authors: moons lmg. Am J Gastroenterol. 2017 May;112(5):785-796. doi: 10.1038/ajg.2017.58. Epub 2017 Mar 21. Am J Gastroenterol. 2017. PMID: 28323275

2

[Acute dysphagia: often there is a readily treatable cause].

Moons LM, Kuipers EJ, Siersema PD. Moons LM, et al. Ned Tijdschr Geneeskd. 2003 Sep 6;147(36):1713-7. Ned Tijdschr Geneeskd. 2003. PMID: 14520793 Dutch.

3

The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.

Moons LM, Bax DA, Kuipers EJ, Van Dekken H, Haringsma J, Van Vliet AH, Siersema PD, Kusters JG. Moons LM, et al. J Clin Pathol. 2004 Oct;57(10):1063-8. doi: 10.1136/jcp.2003.015727. J Clin Pathol. 2004. PMID: 15452161 Free PMC article.

4

Barrett's oesophagus is characterized by a predominantly humoral inflammatory response.

Moons LM, Kusters JG, Bultman E, Kuipers EJ, van Dekken H, Tra WM, Kleinjan A, Kwekkeboom J, van Vliet AH, Siersema PD. Moons LM, et al. J Pathol. 2005 Nov;207(3):269-76. doi: 10.1002/path.1847. J Pathol. 2005. PMID: 16177953

5

IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.

Moons LM, Siersema PD, Kuipers EJ, van Vliet AH, Kusters JG. Moons LM, et al. Am J Gastroenterol. 2005 Dec;100(12):2818. doi: 10.1111/j.1572-0241.2005.00309_6.x. Am J Gastroenterol. 2005. PMID: 16393246 No abstract available.

6

Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?

Kerkhof M, Bax DA, Moons LM, van Vuuren AJ, van Dekken H, Steyerberg EW, Kuipers EJ, Kusters JG, Siersema PD; Cybar Study Group. Kerkhof M, et al. Aliment Pharmacol Ther. 2006 Dec;24(11-12):1613-21. doi: 10.1111/j.1365-2036.2006.03163.x. Aliment Pharmacol Ther. 2006. PMID: 17206949

7

CDX2 expression in columnar metaplasia of the remnant esophagus in patients who underwent esophagectomy.

Bax D, Siersema PD, Moons LM, Dekken Hv, Tilanus HW, Kusters JG, Kuipers EJ. Bax D, et al. J Clin Gastroenterol. 2007 Apr;41(4):375-9. doi: 10.1097/01.mcg.0000225520.36160.52. J Clin Gastroenterol. 2007. PMID: 17413605

8

COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma.

Moons LM, Kuipers EJ, Rygiel AM, Groothuismink AZ, Geldof H, Bode WA, Krishnadath KK, Bergman JJ, van Vliet AH, Siersema PD, Kusters JG. Moons LM, et al. Am J Gastroenterol. 2007 Nov;102(11):2373-9. doi: 10.1111/j.1572-0241.2007.01373.x. Epub 2007 Jun 20. Am J Gastroenterol. 2007. PMID: 17581270

9

A pro-inflammatory genotype predisposes to Barrett's esophagus.

Moons LM, Kusters JG, van Delft JH, Kuipers EJ, Gottschalk R, Geldof H, Bode WA, Stoof J, van Vliet AH, Ketelslegers HB, Kleinjans JC, Siersema PD. Moons LM, et al. Carcinogenesis. 2008 May;29(5):926-31. doi: 10.1093/carcin/bgm241. Epub 2008 Jan 12. Carcinogenesis. 2008. PMID: 18192685

10

Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.

Capello A, Moons LM, Van de Winkel A, Siersema PD, van Dekken H, Kuipers EJ, Kusters JG. Capello A, et al. Am J Gastroenterol. 2008 Jun;103(6):1510-6. doi: 10.1111/j.1572-0241.2008.01908.x. Epub 2008 May 28. Am J Gastroenterol. 2008. PMID: 18510604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters